Published in Curr Cardiol Rev on May 01, 2010
Secondary stroke prevention. Nat Rev Neurol (2010) 0.77
Genetics of resistant hypertension: a novel pharmacogenomics phenotype. Curr Hypertens Rep (2015) 0.76
Intensive risk factor control in stroke prevention. F1000Prime Rep (2013) 0.75
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension (2003) 5.63
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke (2006) 3.67
A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature (1992) 3.40
Can simple clinical measurements detect patient noncompliance? Hypertension (1981) 3.29
Hypertension in sub-Saharan African populations. Circulation (2005) 2.91
Association of hypokalemia, aldosteronism, and renal cysts. N Engl J Med (1990) 2.35
Do family physicians need medical assistants to detect and manage hypertension? CMAJ (1986) 1.85
Aldosterone and vascular inflammation. Hypertension (2008) 1.65
Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J (1966) 1.58
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet (1992) 1.55
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment. J Hypertens (2007) 1.51
Antihypertensive persistence and drug class. Can J Cardiol (2002) 1.48
Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. N Engl J Med (1992) 1.45
Prevalence and control of hypertension in an Ontario county. Can Med Assoc J (1985) 1.33
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens (2009) 1.28
A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension. J Hypertens (2003) 1.23
Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci (2001) 1.12
Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med (1970) 1.11
Effect of non-steroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. Lancet (1986) 1.10
Blood pressure control and risk of stroke: a population-based prospective cohort study. Stroke (2005) 1.10
Differences in hypertension between blacks and whites: an overview. Cardiovasc J Afr (2007) 1.03
Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm. J Am Soc Nephrol (2006) 1.00
Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension (2002) 1.00
Stimulated renin: a screening test for hypertension. Ann Intern Med (1975) 0.96
Update in primary aldosteronism. J Clin Endocrinol Metab (2009) 0.94
Prevalence, treatment, and control of hypertension in primary care: gaps, trends, and opportunities. J Clin Hypertens (Greenwich) (2007) 0.92
Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens (2008) 0.91
Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. Am J Cardiol (2009) 0.84
Antihypertensive drugs and prevention of atherosclerotic stroke. Stroke (1986) 0.83
Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin profiling. Am J Hypertens (1999) 0.83
Salt, slavery and survival- hypertension in the African diaspora. Epidemiology (2003) 0.81
Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension. Cell Mol Biol (Noisy-le-grand) (2006) 0.81
Genetic variation in the epithelial sodium channel: a risk factor for hypertension in people of African origin. Adv Ren Replace Ther (2004) 0.80
Treatment options for renovascular hypertension. Expert Opin Pharmacother (2002) 0.80
The prevalence of adrenal cortical hyperplasia at autopsy and its association with hypertension. Ann Intern Med (1970) 0.78
Diagnosis of primary aldosteronism: for medical management, not just surgery. J Hypertens (2009) 0.77
Trapped renal arteries: functional renal artery stenosis due to occlusion of the aorta in the arch and below the kidneys. Can J Cardiol (2001) 0.77
The pharmacological treatment of primary aldosteronism. Expert Opin Pharmacother (2006) 0.77